Oncotarget

Research Papers:

OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways

Hua Li, Jun Zhang, Mi-Jin Lee, Goung-Ran Yu, Xueji Han and Dae-Ghon Kim _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:18129-18144. https://doi.org/10.18632/oncotarget.15185

Metrics: PDF 1536 views  |   HTML 1324 views  |   ?  


Abstract

Hua Li1, Jun Zhang1, Mi-Jin Lee1, Goung-Ran Yu1, Xueji Han2, Dae-Ghon Kim1

1Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Research Institute of Clinical Medicine, Biomedical Research Institute Chonbuk National University Medical School and Hospital, Jeonju, Jeonbuk, Republic of Korea

2Department of Infectious Disease, Yanbian University Hospital, Yanji, Jilin Province, China

Correspondence to:

Dae-Ghon Kim, email: daeghon@chonbuk.ac.kr

Keywords: OIP5, miR-15b-5p, hepatocellular carcinoma, tumor growth, metastasis

Received: June 29, 2016     Accepted: January 16, 2017     Published: February 08, 2017

ABSTRACT

Opa interacting protein 5 (OIP5) is upregulated in some types of human cancers, but the biological implications of its upregulation have not yet been clarified in human hepatocellular carcinoma (HCC). In this study, the signaling pathway downstream of OIP5 was analyzed by proteome kinase profiling. A putative microRNA targeting OIP5 was identified using a miRNA PCR array. Tumorigenicity and metastatic ability were examined in an orthotopic animal model. OIP5 expression was strongly detected in early and advanced tumors via gene expression profiling and immunohistochemical staining analyses. Cells with knockdown of OIP5 via target shRNA exhibited reduced hepatic mass formation and metastatic tumor nodules in an orthotopic mouse model. OIP5-induced AKT activation was mediated by both mTORC2 and p38/PTEN activation. AKT activation was linked to mTORC1 and GSK-3β/β-catenin signaling, which are primarily associated with tumor cell growth and metastasis, respectively. miR-15b-5p, which targets OIP5, efficiently inhibited OIP5-mediated mTORC1 and GSK-3β/β-catenin signaling. These findings suggest that OIP5 may be involved in HCC growth and metastasis and that miR-15b-5p inhibits OIP5-mediated oncogenic signaling in HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15185